BJR
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text (PDF)
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fayet, P.
Right arrow Articles by Bonnin, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fayet, P.
Right arrow Articles by Bonnin, A.

The British Journal of Radiology, Vol 70, Issue 833 459-464, Copyright © 1997 by British Institute of Radiology

ARTICLES

Technetium-99m sestamibi scintigraphy, magnetic resonance imaging and venous blood sampling in persistent and recurrent hyperparathyroidism

P Fayet, C Hoeffel, Y Fulla, P Legmann, V Hazebroucq, JP Luton, Y Chapuis, B Richard and A Bonnin
Department of Radiology, Cochin Hospital, Paris, France.

Surgical treatment for primary hyperparathyroidism (HPT) is effective in 90% of cases. Recurrent or persistent HPT occurs in 10% of cases. Parathyroid imaging is indicated to confirm and locate an abnormal gland before reoperation. The aim of this study was to evaluate whether the combination of 99Tcm sestamibi scintigraphy, MRI and venous blood sampling (VBS) improved the overall sensitivity for abnormal parathyroid gland detection. 18 patients with recurrent or persistent HPT underwent sestamibi scintigraphy (n = 18), MRI (T1 weighted and STIR sequences) (n = 18) and venous blood sampling (n = 12) at different sites (internal jugular veins, innominate veins, and superior vena cava). All patients underwent surgical exploration. MRI yielded positive results in 15 cases (sensitivity 88%), sestamibi scintigraphy in 14 cases (83%) and VBS in 10 cases out of 12 (83%). Combined results of MRI, sestamibi and VBS yielded positive results in 16 cases (94%). The combination of MRI, sestamibi scintigraphy and VBS improved accuracy in detecting abnormal parathyroid glands before reoperation.


This article has been cited by other articles:


Home page
 Eur J EndocrinolHome page
K. Sejean, S. Calmus, I. Durand-Zaleski, P. Bonnichon, P. Thomopoulos, C. Cormier, P. Legmann, B. Richard, X. Y Bertagna, and G. M Vidal-Trecan
Surgery versus medical follow-up in patients with asymptomatic primary hyperparathyroidism: a decision analysis
Eur. J. Endocrinol., December 1, 2005; 153(6): 915 - 927.
[Abstract] [Full Text] [PDF]

Home page
 Arch SurgHome page
D. Seehofer, T. Steinmuller, N. Rayes, P. Podrabsky, J. Riethmuller, J. Klupp, F. Ulrich, R. Schindler, U. Frei, and P. Neuhaus
Parathyroid Hormone Venous Sampling Before Reoperative Surgery in Renal Hyperparathyroidism: Comparison With Noninvasive Localization Procedures and Review of the Literature
Arch Surg, December 1, 2004; 139(12): 1331 - 1338.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
G. Mariani, S. A. Gulec, D. Rubello, G. Boni, M. Puccini, M. R. Pelizzo, G. Manca, D. Casara, G. Sotti, P. Erba, et al.
Preoperative Localization and Radioguided Parathyroid Surgery
J. Nucl. Med., September 1, 2003; 44(9): 1443 - 1458.
[Abstract] [Full Text] [PDF]

Home page
 RadiologyHome page
M. B. Gotway, G. P. Reddy, W. R. Webb, E. T. Morita, O. H. Clark, and C. B. Higgins
Comparison between MR Imaging and
Radiology, March 1, 2001; 218(3): 783 - 790.
[Abstract] [Full Text]

Home page
 Arch SurgHome page
G. B. Thompson, C. S. Grant, N. D. Perrier, R. Harman, S. F. Hodgson, D. Ilstrup, and J. A. van Heerden
Reoperative Parathyroid Surgery in the Era of Sestamibi Scanning and Intraoperative Parathyroid Hormone Monitoring
Arch Surg, July 1, 1999; 134(7): 699 - 705.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
BJR DMFR IMAGING  ALL BIR JOURNALS 
Copyright © 1997 by the British Institute of Radiology.